Sigyn Therapeutics Completes Reverse Stock Split

Written by Customer Service on February 1, 2024. Posted in Public Companies.

SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a development-stage medical technology company, disclosed today that a 1-for-40 reverse split of its common stock was implemented on January 31, 2024. As a result of the split, the Company’s common stock will trade under the ticker symbol “SIGYD” for 20 business days and subsequently revert to trading under its historic symbol “SIGY” on February 29, 2024. The post-split CUSIP number for the Company’s common stock is 82674U205. The Company also reported 1,221,043 its common shares to be issued and outstanding at the close of trading on January 31, 2024. About Sigyn Therapeutics™ Sigyn Therapeutics is a development-stage medical technology company headquartered in San Diego, California....

HEALWELL AI Completes Acquisition of Intrahealth

Written by Customer Service on February 1, 2024. Posted in Mergers And Acquisitions.

HEALWELL has completed the previously announced acquisition of Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider supporting approximately 15,000 clinicians providing care for millions of patients from small clinics to large health delivery organizations in its global network across Canada, Australia and New Zealand. Intrahealth is expected to generate over $12 million in revenues in 2024, which reflects double digit organic growth. Historically, Intrahealth has achieved over 80% gross margins, produced positive EBITDA, and positive cashflows. Over 80% of its revenue is high margin recurring revenue. HEALWELL’s plan is to deeply integrate its industry leading AI tools with Intrahealth and help create a next generation AI Powered EHR to significantly amplify the effectiveness of healthcare...

Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024

Written by Customer Service on February 1, 2024. Posted in Public Companies.

– Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with company-sponsored webcast on Thursday, February 8, 2024 at 8:00am ET – REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will host a webcast to review preliminary efficacy and safety data from its ongoing LUNA Phase 2 study of ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) on Thursday, February 8th, 2024 at 8:00am ET. The webcast will include Szilard Kiss, M.D., Professor of...

Vertex to Announce Fourth Quarter 2023 Financial Results on Thursday, February 29, 2023

Written by Customer Service on February 1, 2024. Posted in Public Companies.

KING OF PRUSSIA, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release fourth quarter 2023 financial results before the market opens on Thursday, February 29, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-412-317-6026 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 10185697, or via the Company’s Investor Relations website. The replay will expire on March...

Parks! America Files Preliminary Proxy Statement

Written by Customer Service on February 1, 2024. Posted in Public Companies.

Urges Stockholders to Wait to Receive the Company’s Definitive Proxy Statement and WHITE Proxy Card Issues Open Letter to Focused Compounding PINE MOUNTAIN, Georgia, Feb. 01, 2024 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA) (the “Company”) announced today that it has filed its preliminary proxy statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with its Special Meeting of Stockholders (the “Special Meeting”) to be held February 26, 2024. The Company urges stockholders to wait to receive its definitive proxy statement and WHITE Proxy Card in the mail prior to determining how to vote at the Special Meeting. The Company also issued an open letter to Focused Compounding Fund, LP (collectively with its affiliates “Focused Compounding”). The full text of the letter follows. Dear Focused Compounding, As...

Hammond Power Solutions Announces COO Retirement and Appoints Mr. John Bailey as COO

Written by Customer Service on February 1, 2024. Posted in Public Companies.

GUELPH, Ontario, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced the appointment of Mr. John Bailey as Chief Operations Officer (“COO”) effective as of January 1, 2024, who will succeed Mr. Bohdan (Bob) Yusyp who is expected to be retiring in April 2024. “Over the past 15 years, John has grown his career in operations directly under Bob’s mentorship,” said Adrian Thomas, Chief Executive Officer of HPS. “During that time, John has built significant experience working with our clients and strategically planning our operations to meet future demand. From his early days at HPS in production and planning, John quickly progressed to more senior roles, leading special projects such as system conversions, plant start-ups and expansions, successfully reaching the role of...

Koss Corporation Releases Second Quarter Results

Written by Customer Service on February 1, 2024. Posted in Earnings Releases And Operating Results.

MILWAUKEE, Feb. 01, 2024 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the second quarter ended December 31, 2023. Sales for the three months ended December 31, 2023 were $3,360,124 compared to $3,281,333 for the same period in the prior year, an increase of $78,791, or 2.4%. The net loss for the second quarter ended December 31, 2023 was $269,153 compared to a net loss of $1,146,190 for the same three-month period in the prior year. Basic and diluted loss per common share for the quarter was $0.03 compared to basic and diluted loss per common share of $0.12 for the comparable three-month period one year ago. For the six months ended December 31, 2023, net sales of $6,734,062 showed a slight increase of 1.3% versus sales of $6,645,462...

Minerals Technologies Reports Fourth Quarter 2023 Earnings Per Share of $1.22, or $1.28 Excluding Special Items, a Record for Current Quarter

Written by Customer Service on February 1, 2024. Posted in Earnings Releases And Operating Results.

The Company Reports Full Year 2023 Earnings of $2.58, Or $5.21 Per Share, Excluding Special Items, a Record Year for MTI Fourth Quarter Highlights: Record Fourth Quarter Revenue of $525 Million Strong Cash Flow from Operations of $95 Million and Free Cash Flow of $73 Million Increased Dividend and Initiated a New, 1-Year, $75M Share Repurchase Program Full Year Highlights: Record Revenue of $2.17 Billion Record EPS of $5.21, Excluding Special Items Strong Cash Flow from Operations of $234 Million and Free Cash Flow of $140 Million Repaid $49 Million of Debt; Net Leverage Ratio at 1.9 Times EBITDA Reorganized Around Core Technologies and End-Markets, and Announced 5-Year Financial Targets NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today reported diluted earnings...

Ingredion Completes Sale of Business in South Korea

Written by Customer Service on February 1, 2024. Posted in Mergers And Acquisitions.

WESTCHESTER, Ill., Feb. 01, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced that it has completed the sale of its business in South Korea to an affiliate of the Sajo Group, a leading food company headquartered in Seoul, South Korea, for approximately USD $294 million, with $247 million, net of transaction costs, received on February 1, 2024, and the remainder to be received over the next three years. The transaction was announced on November 13, 2023. For the full-year 2023, Ingredion’s business in South Korea delivered net sales of $325 million (unaudited). “The sale of our business in South Korea is an important step for Ingredion as we reshape our portfolio to unlock value and redeploy assets to create value for...

Guggenheim Investments Announces February 2024 Closed-End Fund Distributions

Written by Customer Service on February 1, 2024. Posted in Dividend Reports And Estimates.

NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”). The following dates apply to the distributions: Record Date February 15, 2024 Ex-Dividend Date February 14, 2024 Payable Date February 29, 2024 Distribution Schedule NYSE Ticker Closed-End Fund Name Distribution Per Share Change from Previous Distribution Frequency AVK Advent Convertible and Income Fund $0.1172† Monthly GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust $0.12573† Monthly GOF Guggenheim Strategic Opportunities Fund $0.1821† Monthly GUG Guggenheim Active Allocation Fund $0.11875† Monthly † A...

Day: February 1, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice